Stage III melanoma marks a significant turning point in the journey of skin cancer, where cancer cells have traveled beyond the original tumor site to nearby lymph nodes or surrounding skin areas, yet haven’t reached distant organs. Understanding this stage can help patients and their families navigate treatment decisions and face the future with knowledge and preparation.
What Stage III Melanoma Really Means
When doctors diagnose stage III melanoma, they are describing a regional melanoma—meaning the cancer has spread from where it first appeared on the skin to nearby areas of the body, but not to distant organs. This is different from earlier stages where the cancer stays only in the skin, and from stage IV where it reaches far-away parts of the body like the lungs, liver, or brain.[1]
The lymph nodes play a central role in understanding stage III melanoma. These are small, bean-shaped structures that form part of the lymphatic system—a vast network throughout your body that helps remove waste, toxins, and unwanted materials while supporting your immune system by transporting infection-fighting white blood cells. When melanoma reaches stage III, cancer cells have typically moved into these lymph nodes near the original tumor, into the lymph vessels that connect them, or into patches of skin around the primary melanoma site.[1]
Stage III melanoma is not a single, uniform condition. Doctors divide it into four subgroups—IIIA, IIIB, IIIC, and IIID—based on specific characteristics. These characteristics include how thick the original tumor was, whether the top layer of the melanoma appeared broken or ulcerated when examined under a microscope, how many lymph nodes contain cancer cells, and whether cancer has spread to nearby skin areas. This detailed classification helps doctors predict outcomes and choose the most appropriate treatment approach for each individual.[1][3]
Understanding the subgroups can feel overwhelming, but here’s what matters most: Stage IIIA generally represents less extensive spread, with smaller tumors and fewer affected lymph nodes. As the substage letters progress through B, C, and D, they typically indicate more extensive involvement—either larger or ulcerated primary tumors, more lymph nodes containing cancer, or cancer deposits in the skin between the primary tumor and lymph nodes or beyond.[1][7]
Different Patterns of Spread in Stage III
Stage III melanoma can show several different patterns of spread, and doctors use specific terms to describe each one. When cancer cells are found between the original melanoma and nearby lymph nodes, they’re given special names based on how far they’ve traveled and how much cancer is present.[3][8]
Microsatellite metastases are tiny amounts of cancer cells found very close to the primary melanoma—so small they can only be seen through a microscope. Satellite metastases refer to cancer cells found within 2 centimeters of the original melanoma site. In-transit metastases describe cancer cells that have spread more than 2 centimeters away from the melanoma but haven’t yet reached the nearest lymph node. These cancer deposits represent melanoma cells that began traveling through lymph vessels but stopped somewhere along the way rather than completing the journey to a lymph node.[3][8]
Sometimes doctors find melanoma cells in lymph nodes or nearby areas but cannot locate the original primary melanoma on the skin. This doesn’t change the stage III diagnosis—it simply means the body may have eliminated the original tumor site naturally, or it was too small to find during examination.[3]
How Doctors Determine the Stage
Determining whether melanoma has reached stage III requires several steps and different types of testing. The process begins when a doctor removes the abnormal area of skin along with a small margin of surrounding normal skin. This procedure, called an excision biopsy, provides the first crucial piece of information. A specialist doctor called a pathologist examines this tissue under a microscope, looking for melanoma cells and measuring important characteristics like thickness and whether the surface appears broken or ulcerated.[3][8]
If melanoma is confirmed, the next important step usually involves checking the lymph nodes. The most common test is called a sentinel lymph node biopsy. This procedure identifies and removes the first lymph node or nodes that the melanoma would most likely spread to based on the tumor’s location. Doctors inject a special dye or radioactive tracer near the melanoma site, then follow where it flows to find these sentinel nodes. If cancer cells are found in these nodes, it confirms stage III melanoma. This biopsy typically happens at the same time as a wider surgical removal of the primary melanoma site, called a wide local excision.[3][8]
When lymph nodes near the melanoma feel swollen or enlarged during a physical examination, doctors usually take a different approach. Instead of a sentinel node biopsy, they perform an ultrasound scan of the area and may take a tissue sample directly from the enlarged node to check for cancer cells. Additional scans and tests help doctors see the complete picture and ensure the cancer hasn’t spread beyond the regional area.[3][8]
Risk of Recurrence After Treatment
One of the most difficult aspects of stage III melanoma is understanding and facing the risk that cancer could return or spread further, even after successful surgery. This return of cancer is called recurrence. Even when surgeons completely remove the melanoma and affected lymph nodes, microscopic cancer cells may remain in the body, invisible to current tests. These cells can potentially grow over time, leading to cancer coming back either in the same area or in distant parts of the body.[9]
Research examining medical records of stage III melanoma patients who chose to “watch and wait” without additional treatment after surgery revealed concerning patterns. In one study, 50 percent of these patients—125 out of 251 people—experienced cancer recurrence. Of those who had recurrence, 53 percent found that their cancer had spread to other parts of the body beyond the original region. This data helps explain why doctors often recommend additional treatment after surgery rather than simply monitoring.[9]
The same study also examined patients who received treatment after their surgery. Among these individuals, 33 percent—43 out of 129 people—had their cancer return. When recurrence did occur, 47 percent of these cases involved spread to other body parts. While these numbers are still significant and concerning, they show a lower rate of recurrence compared to those who didn’t receive post-surgery treatment. This information helps patients and doctors weigh the potential benefits and risks of additional therapy after surgical removal of stage III melanoma.[9]
The risk of melanoma recurrence can range widely, with studies indicating that patients with stage III disease face approximately 40 to 90 percent risk of recurrence within five years following surgery alone. This broad range exists because different subgroups within stage III (A, B, C, and D) carry different levels of risk. More extensive disease at diagnosis typically corresponds with higher recurrence risk, which is why determining the precise substage matters so much for treatment planning.[10]
Treatment Approaches for Stage III Melanoma
Surgery remains the cornerstone treatment for stage III melanoma. When cancer cells are confined to lymph nodes that can be completely removed through an operation, surgery offers the best chance for eliminating visible disease. The surgical procedure typically involves removing the primary melanoma site with surrounding healthy tissue margins, plus removing affected lymph nodes in a procedure called lymph node dissection. The goal is to take out all detectable cancer while preserving as much normal function as possible.[3][8]
However, surgery alone often isn’t enough for stage III melanoma because of the high risk of hidden microscopic disease remaining in the body. This is where additional treatments after surgery, called adjuvant therapy, become important. Adjuvant treatments target those invisible cancer cells that might have escaped the original tumor site but are too small to detect with current technology. By treating the whole body systemically, these therapies aim to prevent recurrence and improve long-term survival.[10]
In recent years, two main types of adjuvant treatment have shown significant benefit for stage III melanoma: immunotherapy and targeted therapy. Immunotherapy works by enhancing the body’s own immune system to recognize and destroy cancer cells. These treatments help remove the brakes that melanoma cells put on immune responses, allowing the body’s natural defenses to work more effectively. Several immunotherapy drugs have been approved specifically for treating stage III melanoma after surgery.[10]
One immunotherapy approach tested in clinical trials compared giving patients an immunotherapy drug called pembrolizumab (brand name KEYTRUDA) every three weeks after surgery versus giving them a placebo or inactive treatment. The results showed that 74 percent of people receiving the immunotherapy (379 out of 514) did not have their melanoma return at the time of follow-up, compared to only 57 percent (289 out of 505) in the placebo group. Additionally, 66 percent of those receiving immunotherapy were alive without their melanoma spreading to distant body parts, compared to 51 percent in the placebo group. These results demonstrate how post-surgery treatment can meaningfully improve outcomes for stage III melanoma patients.[9]
Targeted therapy represents another treatment option, particularly for patients whose melanoma cells carry specific genetic changes. Some melanomas have mutations in genes like BRAF, which cause abnormal signals that make cancer cells grow and divide rapidly. Targeted therapy drugs are designed to block these specific abnormal signals. However, these treatments only work for patients whose tumors have the relevant genetic mutations, which is why testing the melanoma tissue for these changes is an important part of treatment planning.[10]
Some people with stage III melanoma may receive other treatments instead of or in addition to surgery. These might include chemotherapy, radiation therapy, or combinations of different treatment approaches. The specific treatment plan depends on multiple factors including where the melanoma is located, how extensive the spread is, the patient’s overall health and fitness level, and individual preferences after discussions with their medical team.[3][8]
The Causes Behind Melanoma Development
Understanding what causes melanoma can provide important context for anyone facing a stage III diagnosis, even though this knowledge doesn’t change the current situation. Melanoma develops when melanocytes—the cells that produce skin color pigment called melanin—undergo changes that cause them to grow out of control and become cancerous. While the exact trigger for these changes isn’t always clear in individual cases, research has identified several major contributing factors.[5]
The overwhelming evidence points to ultraviolet (UV) radiation as the primary cause of most melanomas. UV rays, whether from natural sunlight or artificial sources like tanning beds, can damage the DNA inside skin cells. When this damage affects specific genes that control how cells grow and divide, it can lead to cancer development. Studies show that approximately 86 percent of melanomas are caused by exposure to solar UV rays. This damage accumulates over a lifetime, which means both childhood sun exposure and adult tanning contribute to melanoma risk.[5]
Sunburns, especially severe blistering sunburns during childhood and adolescence, appear particularly dangerous for melanoma development. Each severe sunburn represents an episode of intense DNA damage to skin cells. While the body has mechanisms to repair this damage, the repair process isn’t perfect, and errors can accumulate. Years or even decades may pass between damaging sun exposure and the development of visible melanoma, which explains why melanoma rates increase with age even if someone has avoided the sun for many years.[5]
Indoor tanning deserves special attention as a melanoma cause. Tanning beds and sun lamps emit concentrated UV radiation, sometimes at intensities higher than midday sun. People who use tanning beds face significantly increased melanoma risk, and this risk grows with more frequent use and younger age of first use. The idea that a “base tan” provides protection is dangerously false—any tan represents skin damage and increased cancer risk.[5]
Risk Factors That Increase Melanoma Likelihood
While anyone can develop melanoma, certain characteristics and circumstances increase the likelihood. Understanding these risk factors helps explain why some people develop melanoma while others don’t, even with similar sun exposure patterns. Risk factors represent probabilities and tendencies rather than certainties—having risk factors doesn’t guarantee melanoma development, and lacking them doesn’t provide complete protection.[5]
Skin type plays a major role in melanoma risk. People with fair or pale skin that burns easily and tans poorly face higher risk than those with darker skin. Blonde or red hair combined with blue, green, or gray eyes also indicates increased susceptibility. This connection exists because lighter skin contains less melanin pigment, which provides some natural protection against UV damage. However, people with any skin tone can develop melanoma, and darker-skinned individuals often face worse outcomes because melanomas may be detected later or in more dangerous locations like the palms, soles, or under nails.[5]
Having many moles on your body increases melanoma risk. While most moles never become cancerous, people with 50 or more ordinary moles, or those with unusual-looking moles called dysplastic nevi, face higher risk. Large moles present at birth, called congenital nevi, also carry increased melanoma risk. The number of moles may serve as a marker for both genetic susceptibility to melanoma and cumulative sun damage.[5]
Personal and family history strongly influence melanoma risk. Anyone who has already had melanoma faces significantly increased risk of developing a second, separate melanoma. Family history also matters—having a close blood relative (parent, sibling, or child) with melanoma increases risk. In some families, inherited genetic changes passed down through generations create very high melanoma susceptibility. Genetic testing can identify some of these inherited risk factors, though most melanomas occur in people without identified genetic mutations.[5]
Age affects melanoma risk, with rates generally increasing as people get older, likely reflecting cumulative UV damage over decades. However, melanoma also occurs in young adults and is one of the most common cancers in people under 30, particularly young women. Before age 50, melanoma rates are actually higher in women than men, but after age 50, rates become much higher in men. These gender differences likely reflect both behavioral patterns related to sun exposure and possibly hormonal or biological factors.[5]
A weakened immune system increases melanoma risk. This includes people who have received organ transplants and take immune-suppressing medications, those living with HIV/AIDS, and individuals taking medications that suppress immune function for other medical conditions. A properly functioning immune system helps identify and eliminate abnormal cells before they become cancer, so when this surveillance system is compromised, cancer risk rises.[5]
Recognizing Melanoma Symptoms and Warning Signs
Most stage III melanomas begin as visible changes on the skin that gradually evolve over weeks or months. Learning to recognize potential melanoma allows for earlier detection, which dramatically improves treatment success. While stage III indicates that spread has already occurred, understanding what melanoma looks like remains important for monitoring for any new growths after treatment.[5]
The most useful tool for identifying possible melanoma is the ABCDE rule, which describes five warning characteristics. Asymmetry means one half of the spot doesn’t match the other half—if you drew a line through the middle, the two sides would look different. Border irregularity refers to edges that appear ragged, notched, or blurred rather than smooth and even. Color variation means the spot shows multiple different shades or colors—brown, black, tan, red, white, or blue—rather than being uniformly one color. Diameter traditionally means larger than 6 millimeters (about the size of a pencil eraser), though melanomas can certainly be smaller than this. Evolving describes any mole or skin mark that is changing in size, shape, color, or other characteristics.[5]
Some melanomas don’t fit the ABCDE pattern. They may appear as unusual bumps, non-healing sores, or scaly patches. Some are pink or red rather than dark colored. The “ugly duckling” sign provides another useful guideline—if one spot on your skin looks noticeably different from all your other moles or marks, it deserves medical evaluation even if it doesn’t obviously meet ABCDE criteria.[5]
About 30 percent of melanomas develop within existing moles, while 70 percent appear as completely new spots on previously normal skin. This means both changes to existing moles and the appearance of new, unusual marks warrant attention. After treatment for stage III melanoma, continued vigilance for any suspicious changes becomes even more important given the risk of developing a second melanoma.[5]
Prevention Strategies to Reduce Risk
While prevention advice may seem less relevant after a stage III diagnosis, understanding prevention remains important for several reasons. Family members may benefit from this information to reduce their own risk. Additionally, preventing additional melanomas remains crucial for melanoma survivors, who face elevated risk of developing a second primary melanoma.[5]
Sun protection forms the foundation of melanoma prevention. This means minimizing UV exposure through several strategies used together. Seeking shade, especially during midday hours when the sun’s rays are strongest (typically 10 AM to 4 PM), significantly reduces exposure. Wearing protective clothing including long-sleeved shirts, long pants, wide-brimmed hats, and UV-blocking sunglasses provides physical barriers against UV radiation.[5]
Using sunscreen correctly helps reduce risk, though sunscreen alone isn’t sufficient protection. Broad-spectrum sunscreen that blocks both UVA and UVB rays, with SPF 30 or higher, should be applied generously to all exposed skin 30 minutes before going outdoors, then reapplied every two hours and after swimming or sweating heavily. However, sunscreen should supplement rather than replace shade and protective clothing. Many people apply far less sunscreen than needed for the labeled SPF protection, creating a false sense of security.[5]
Avoiding indoor tanning entirely is critical. There is no safe way to use tanning beds. The UV radiation they emit damages DNA and increases melanoma risk in addition to causing premature skin aging. Some regions have banned indoor tanning for minors, recognizing the particular danger of early-life UV exposure. For anyone concerned about pale skin appearance, self-tanning products that temporarily stain the skin’s surface offer a much safer alternative, though they don’t provide UV protection.[5]
Regular skin examinations by both medical professionals and through self-examination help detect melanoma earlier when it’s most treatable. Healthcare providers recommend that people at increased melanoma risk have professional skin exams at intervals determined by their risk level. Self-examination involves checking your entire skin surface monthly, looking for new spots or changes to existing marks. Using a mirror or asking a partner to check hard-to-see areas like the back and scalp ensures complete coverage. Taking photographs of moles can help track whether they’re changing over time.[5]
How Melanoma Changes the Body
Understanding the biological changes that occur with melanoma, called pathophysiology, helps explain both the disease’s behavior and why certain treatments might work. Normal melanocytes live in the deepest layer of the epidermis, the skin’s outer covering. Their job is producing melanin, the pigment that gives skin its color and provides some protection against UV damage. These cells normally divide in a controlled way, replacing themselves as needed while responding to signals from surrounding cells that regulate their growth.[5]
When melanoma develops, melanocytes undergo genetic changes—mutations in their DNA—that disrupt normal growth control. These mutated cells begin dividing without proper regulation, ignoring the signals that normally keep cell growth in check. They accumulate additional genetic abnormalities over time, developing new characteristics that make them increasingly dangerous. These changes allow melanoma cells to grow aggressively, invade deeper into skin layers, and eventually develop the ability to survive in locations far from where they originated.[5]
In stage III melanoma, cancer cells have acquired the ability to travel from the primary tumor site. They do this by breaking away from the original tumor and entering either lymphatic vessels (thin tubes that carry lymph fluid throughout the body) or small blood vessels in the skin. Lymphatic vessels naturally drain fluid from tissues and filter it through lymph nodes, so melanoma cells entering these vessels often get carried to nearby lymph nodes, where they can lodge and begin growing. Some melanoma cells traveling through lymph vessels don’t make it all the way to a lymph node but instead stop somewhere along the path, creating satellite or in-transit metastases in the skin.[1][3]
The lymph nodes themselves serve as filters for lymph fluid, trapping bacteria, viruses, and other foreign material including cancer cells. When melanoma cells reach a lymph node, the immune system should ideally recognize and destroy them. However, melanoma cells develop strategies to evade immune destruction. They may produce signals that suppress immune responses, or they may express proteins on their surface that essentially tell immune cells to leave them alone. This immune evasion allows melanoma cells to survive and multiply within lymph nodes despite being surrounded by immune system components.[1]
The thickness of the original melanoma tumor and whether its surface appears ulcerated relate to how far the cancer has progressed in terms of these biological changes. Thicker tumors have undergone more rounds of abnormal cell division, accumulating more genetic abnormalities and potentially more aggressive characteristics. Ulceration means the skin covering the melanoma has broken down, which may indicate that the tumor is growing rapidly and disrupting normal tissue structures. Both factors correlate with higher risk that melanoma cells have gained the ability to spread successfully to other body parts.[1][7]
Understanding these biological mechanisms helps explain why immunotherapy has become so important in treating stage III melanoma. These treatments work by removing the brakes that melanoma cells put on the immune system. They essentially unmask cancer cells or restore the immune system’s ability to recognize and attack them. Since stage III melanoma cells have already demonstrated ability to survive in lymph nodes despite being surrounded by immune cells, helping the immune system overcome melanoma’s evasion strategies makes biological sense as a treatment approach.[10]
